COMMUNITY OUTREACH AND ENGAGEMENT ABSTRACT Cancer is the second leading cause of death in Utah, and Huntsman Cancer Institute (HCI) is the official Cancer Center of the State of Utah, pursuant to a 2005 legislative resolution. In recognition of this charge and the fact that >80% of HCI?s cancer patient population is from Utah, HCI defines its catchment area as the State of Utah. Further, HCI also serves as the only National Cancer Institute (NCI)-designated Cancer Center in the vast Mountain West region of the USA that includes Utah, Idaho, Montana, Nevada, and Wyoming. Through thoughtful monitoring of the cancer landscape in Utah, HCI has identified, invested in, and promoted research, prevention, and policy measures to address pressing needs of our catchment area, with the goal to achieve the greatest and most sustainable impact. Three primary focus areas of our efforts include: 1) Melanoma/Sun Safety: Utah has the highest melanoma incidence in the nation; 2) Lung Cancer/Tobacco Control/Radon Reduction: Lung cancer is the leading cause of cancer death in Utah; 3) Rural/Frontier and other Disparity Populations: Major opportunities to address cancer health equity due to Utah's rural/frontier geography and demographics. In addition, we have invested in areas with opportunities for innovation and impact based on features of our catchment area: 1) Top Five Cancers in Utah for Incidence or Mortality; 2) Inherited Cancer Risk; 3) Pediatric/Adolescent Cancers; 4) Prevention of HPV-Related Cancers. HCI?s Community Outreach and Engagement (COE) efforts encompass two major components. The Center for HOPE (Health Outcomes and Population Equity) leads our community-engaged and implementation research efforts to improve cancer-related population health, and the Community Outreach and Prevention Education office provides outreach and education about cancer risk, prevention, and care to patients and communities throughout Utah. HCI has an impressive portfolio of catchment-area relevant research, ranging from basic- science discovery and investigator-initiated clinical trials in our areas of focus, to a recently submitted Melanoma SPORE, and large team science grants that engage Utah?s Federally Qualified Health Centers. Finally, COE efforts align with our educational programs to address health equity, which include our CURE PathMaker Program and GMaP. HCI also works closely with two major community partners, HCI?s 38-member Community Advisory Board and the Utah Cancer Action Network, to establish priorities for services, outreach, education, and research. Through these and other state-wide and broader partnerships, HCI translates science to the community. We have been successful in achieving and continue to drive policy improvements at local and national levels, with particular emphasis on cancer-related topics of relevance to Utah.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935890
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Hellwig, Sabine; Nix, David A; Gligorich, Keith M et al. (2018) Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. PLoS One 13:e0197333
Fleming, Aaron M; Zhu, Judy; Ding, Yun et al. (2018) Human DNA Repair Genes Possess Potential G-Quadruplex Sequences in Their Promoters and 5'-Untranslated Regions. Biochemistry 57:991-1002
Martin, Christopher; Leiser, Claire L; O'Neil, Brock et al. (2018) Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study. J Natl Cancer Inst 110:527-533
Mollaoglu, Gurkan; Jones, Alex; Wait, Sarah J et al. (2018) The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity 49:764-779.e9
Sorenson, Reed S; Deshotel, Malia J; Johnson, Katrina et al. (2018) Arabidopsis mRNA decay landscape arises from specialized RNA decay substrates, decapping-mediated feedback, and redundancy. Proc Natl Acad Sci U S A 115:E1485-E1494
Polanco, Edward R; Western, Nicholas; Zangle, Thomas A (2018) Fabrication of Refractive-index-matched Devices for Biomedical Microfluidics. J Vis Exp :
Camolotto, Soledad A; Pattabiraman, Shrivatsav; Mosbruger, Timothy L et al. (2018) FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. Elife 7:
Nevala-Plagemann, Christopher; Francis, Samual; Cavalieri, Courtney et al. (2018) Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. ESMO Open 3:e000386
Li, Lian; Yang, Jiyuan; Wang, Jiawei et al. (2018) Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 12:3658-3670
Wu, Yelena P; Nagelhout, Elizabeth; Aspinwall, Lisa G et al. (2018) A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma. Patient Educ Couns 101:452-459

Showing the most recent 10 out of 1193 publications